Supporting Innovations in Patient Care

Patients’ needs and safety guide our steps. We are committed to developing and supporting innovations that help healthcare professionals to make informed care decisions. Through investments in technology, clinical decision tools, and research, we work to ensure healthcare professionals have the information they need to thoughtfully address individual patient needs. These efforts include:

Patient-Focused Research Collaboration

  • Supporting innovative research to advance pain care approaches through investigator-led studies focused on developing clinically relevant and useful tools to help evaluate chronic pain. The assessment of pain levels is important in making a correct diagnosis, determining appropriate therapy, and studying responses to treatment.
  • Collaborating with the National Institutes of Health (NIH), as recommended by President Trump’s Opioid Commission, toward the creation of a public-private partnership focused on accelerating the development of treatments for opioid use disorders and non-opioid, non-addictive pain medications.

Medication Safety, Storage, and Disposal

  • Collaborating with the US Conference of Mayors (USCM) to provide awards to cities for the “Safeguard My Meds Prescription Drug Abuse Prevention Recognition Program” to honor outstanding initiatives that address prescription drug misuse and abuse in America’s cities.
  • Partnering with Project Lazarus and Safe Kids North Carolina to support state-wide medicine disposal activities and conduct systematic research to evaluate the impact of community-based prevention programs on opioid-related overdoses, abuse, and diversion.
  • Supporting Risk Evaluation and Mitigation Strategies (REMs), which include patient counseling information.

Clinical Decision Tools

We believe doctors should check their state Prescription Drug Monitoring Program (PDMP) databases before writing a controlled substance prescription, and we encourage prescribers to register and use PDMPs. Evidence shows PDMPs are effective in supporting appropriate clinical decision-making and reducing doctor shopping.

We work to improve information sharing by:

  • Supporting and promoting improved PDMP utility for clinicians such as accessing data across state lines, allowing use by a prescriber’s delegate, and integrating information into the clinical workflow.
  • Improving care coordination through a public-private partnership with the Commonwealth of Virginia. This initiative integrates prescription monitoring program data into the regular workflow of doctors, nurses, and pharmacists.

We also provided a $1 million grant to the National Association of Boards of Pharmacy (NABP), which enabled NABP to provide the prescription monitoring program InterConnect to states, allowing the interstate sharing of prescription data at no cost to help deter doctor-shopping. It is now used by more than 40 states.

The prescription and illicit opioid abuse crisis is a multifaceted public health challenge, and as a manufacturer of prescription opioids, we have a responsibility to join the fight. At Purdue we are committed to lead our industry in helping address our nation's prescription and illicit opioid abuse crisis.

There is more to come – as we continue to work with partners and experts to deliver solutions. Below you will find additional information about our efforts.

Read our open letter about the opioid crisis.